Aquilo Capital Management as of March 31, 2023
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 12 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 29.3 | $71M | 220k | 320.93 | |
| Blueprint Medicines (BPMC) | 11.6 | $28M | 623k | 44.99 | |
| Arrowhead Pharmaceuticals (ARWR) | 10.7 | $26M | 1.0M | 25.40 | |
| Merus N V (MRUS) | 9.3 | $23M | 1.2M | 18.40 | |
| Kymera Therapeutics (KYMR) | 7.4 | $18M | 601k | 29.63 | |
| Arvinas Ord (ARVN) | 7.1 | $17M | 629k | 27.32 | |
| Regenxbio Inc equity us cm (RGNX) | 6.5 | $16M | 831k | 18.91 | |
| Uniqure Nv SHS (QURE) | 5.3 | $13M | 638k | 20.14 | |
| Genmab A/s Sponsored Ads (GMAB) | 3.8 | $9.2M | 243k | 37.76 | |
| Argenx Se Sponsored Adr (ARGX) | 3.7 | $8.9M | 24k | 372.58 | |
| Silence Therapeutics Ads (SLN) | 3.4 | $8.1M | 1.3M | 6.20 | |
| Pieris Pharmaceuticals | 1.8 | $4.4M | 4.6M | 0.98 |
